Aravind Rengan

65PUBLICATIONS
87CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Metal organic frameworksPolymers and plasticsMain group metal chemistryMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Oct 01, 2026
Tumour selective redox activity of economically synthesised Ferromarin in triple-negative breast cancer.

|Aug 20, 2026
Architectural Tuning of Ruthenium Centers to Drive Mitochondria-Mediated Apoptosis in Melanoma Cells.

|Aug 20, 2026
Fabrication of a Silk-Glycerol-Based Flexible Electrode Decorated with WO3 Nanorods for Ultrasensitive Electrochemical Detection of Bacteria.

|Jul 23, 2026
Heavy-Atom Driven Enhancement of Solid-State Luminescence in Cd(II)-Halide N-Heterocyclic Chalcogenones.

|Jun 17, 2026
Investigation on the Cytotoxicity of Hydroxycinnamic and Hydroxybenzoic Acid-Based Natural Antioxidant Conjugated Terpyridine Analogues toward Triple-Negative Breast Cancer.

|Mar 16, 2026
Multitargeted Anticancer Strategy through DNA Damage and Mitochondrial Collapse by a Ferrocene-Benzimidazolium Salt.

Nitisha Beniwal, Bikash Lahkar, Girbide Amitkumar Ramakant

Pageof 11

Frequent Collaborators

7 joint publications

Ganesan Prabusankar

4 joint publications

Kalyani Eswar

4 joint publications

Siva Rama Krishna Vanjari

4 joint publications

Bikash Lahkar